Nahid YUNUSOV, Selahattin BEDİR, Fahri Yavuz İLKİ, Turgay EBİLOĞLU
Journal of Urological Surgery - 2026;13(2):96-101
Objective: To evaluate the effect of bipolar radiofrequency (RF) ablation therapy on prostate volume, urinary flow rates, post-void residual urine volume (PVR), and symptom scores in benign prostatic hyperplasia (BPH) patients. Materials and Methods: A retrospective analysis was conducted on 40 BPH patients who underwent bipolar RF ablation between November 2017 and June 2018 after failed medical treatment. Prostate volume, International Prostate Symptom Score (IPSS), Qmax, Qave, and PVR were assessed before treatment, and at 1, 3 months and 1 year post-treatment. Results: The mean age was 72.8 years. Prostate volume decreased by 12.6% from 53.06+/-19.53 mL to 46.34+/-21.15 mL at 1 year, although this change was not statistically significant (p=0.105). PVR showed a significant reduction from 148.83+/-103.18 mL to 106.37+/-100.26 mL (p=0.0018). Maximum urinary flow rate (Qmax) increased by 48.3% from 11.03+/-6.62 to 16.36+/-6.70 mL/s at 3 months, and remained stable at 16.10+/-6.12 mL/s at 1 year. The IPSS improved significantly from 21.86+/-7.61 to 13.30+/-7.14 at 3 months, and further to 10.40+/-3.64 at 1 year (p<0.001). No major complications were observed throughout the follow-up period. Conclusion: Bipolar RF ablation is a safe and effective minimally invasive treatment for BPH, especially in patients with high surgical risk. It significantly improves urinary parameters and symptom scores.
